Journal of Modern Urology 2025;30(9):727-732
doi:10.3969/j.issn.1009-8291.2025.09.001
Research advances on oncolytic viruses and their vectors for bladder cancer treatment
Zhenxing ZHAI 1 ; Zhiping WANG 1
Affiliations
Keywords
bladder cancer; oncolytic virus; viral vector; adenovirus vector; lentiviral vector; adeno-associated virus vector; immunotherapy; chemotherapy; radiotherapy
Country
China
Language
Chinese
Abstract
Bladder cancer has the characteristics of multiple and easy recurrence after surgery.At present,the main treatment methods include surgery,chemotherapy,radiotherapy,and so on.However,the recurrence rate and metastasis rate are still very high,seriously threatening human health.Oncolytic viruses have become an important part of a comprehensive cancer treatment strategy.Compared with surgery,radiotherapy and chemotherapy,oncolytic virus therapy is more precise and less toxic,which is expected to significantly improve patients' quality of life.However,the therapeutic effects of oncolytic viruses alone are satisfactory.Currently,oncolytic viruses are combined with immunotherapy,chemotherapy or radiotherapy to improve the overall anti-tumor effects.The combination of oncolytic viruses and immunotherapy has a relatively broader prospect.This article reviews the research progress of the clinical application of adenovirus vectors,lentiviral vectors,adeno-associated virus vectors,and oncolytic viruses combined with immunotherapy,chemotherapy,and radiotherapy for bladder cancer.
备案号: 11010502037788, 京ICP备10218182号-8)